Skip to content

Libman-Sacks endocarditis

Cardiology / Rheumatology / PathologyCardiovascularImmuneMusculoskeletal/Connective TissueHematologic

Summary

Libman-Sacks endocarditis is a sterile, nonbacterial verrucous endocarditis classically associated with systemic lupus erythematosus (SLE) and antiphospholipid syndrome. Small, warty vegetations form on both surfaces of the valves (most often mitral), and they can cause embolic events or valvular regurgitation.

Detail

**Definition:** A form of nonbacterial thrombotic (verrucous) endocarditis seen in autoimmune disease, mainly SLE and secondary/primary antiphospholipid syndrome (APS).

**Pathophysiology:** - Immune complex deposition and antiphospholipid antibodies (lupus anticoagulant, anticardiolipin, anti-β2-glycoprotein I) cause valvular endothelial injury and a hypercoagulable state. - Platelets and fibrin deposit on the damaged valve, with fibrinoid necrosis, inflammation, and later fibrosis and scarring. - Vegetations are sterile, so blood cultures are negative.

**Pathology (high-yield):** - Small (1–4 mm), warty, friable, **verrucous** vegetations. - They form on **both the upper and lower surfaces of the valve leaflets**, which is a classic distinguishing feature. They can also involve the undersurface, chordae, and mural endocardium. - The **mitral valve** is most commonly affected, then the aortic valve. - Histology shows fibrin, platelets, and inflammatory cells, with hematoxylin bodies in SLE.

**Clinical features:** - Often asymptomatic and found incidentally on echocardiography or at autopsy. - Valvular regurgitation (mitral or aortic) can develop, and stenosis is less common. - The main complication is **systemic embolization**, which can cause stroke or TIA, peripheral emboli, or renal infarcts. - It can serve as a nidus for superimposed infective endocarditis.

**Diagnosis:** - Echocardiography, with TEE more sensitive than TTE, shows irregular valve thickening and vegetations. - Negative blood cultures help distinguish it from infective endocarditis. - Check antiphospholipid antibodies, ANA, and anti-dsDNA.

**Treatment:** - Treat the underlying disease with glucocorticoids and immunosuppression for active SLE. - Anticoagulation (warfarin) is used for APS or embolic events. DOACs are generally avoided in APS, especially triple-positive APS. - Surgery is reserved for severe valvular dysfunction or recurrent emboli despite anticoagulation.

**Board comparison of vegetations:** - **Infective endocarditis:** large, friable vegetations. *S. aureus* affects normal valves and IV drug users (tricuspid), and viridans streptococci affect damaged valves. - **Nonbacterial thrombotic endocarditis (marantic):** small, bland vegetations along the **line of closure**. It is associated with malignancy (especially mucinous adenocarcinoma) and hypercoagulable states. - **Rheumatic heart disease:** small vegetations along the line of closure, with Aschoff bodies, "fish-mouth" mitral stenosis, and a history of group A strep. - **Libman-Sacks:** small to medium vegetations on **both sides** of the valve, associated with SLE.

**Mnemonic:** "SLE → Libman-Sacks → Sterile, on Several surfaces (both sides of the valve)." Another is "Libman-Sacks = Lupus = Look on both sides."

**Associated:** SLE, APS, possibly other autoimmune conditions. The vegetations are sterile and the cultures negative.

Sources

  • First Aid for the USMLE Step 1 (Cardiovascular – Endocarditis; Rheumatology – SLE)
  • Robbins & Cotran Pathologic Basis of Disease (Valvular Heart Disease – Noninfected Vegetations)
  • Harrison's Principles of Internal Medicine (SLE; Antiphospholipid Syndrome)
  • Pathoma (Fundamentals of Pathology – Cardiac Pathology)
  • UpToDate: Cardiac manifestations of systemic lupus erythematosus

Reviewed by Medusa editorial — medical student review. Information here is for study reference only and is not medical advice. Spotted an error? Let us know.